CAS: 135944-06-8; Dl-N-Fmoc-2'-Methylphenylalanine

该化合物是氨酸苯丙氨保护组的衍生物,用氟烯酰氟甲基苯丙胺(Fmoc)进行修改,其特点是用于peptide合成,特别是用于固相peptide合成(SPPS),该组在基本条件下可以轻易去除.苯丙胺侧链上存在2甲基组会增强其疏水性,从而影响peptides的折叠和稳定性.氟乙烯组有助于化合物在有机溶剂中的稳定性和溶性,使之适合各种合成用途.此外,该化合物的结构允许生物系统中的潜在互动,从而引起对药用化学和药物设计的兴趣.

结构式图片

MSDS等安全信息

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-8338565-B2
    优先权日:2008-08-20
    标 题 :Macrocyclic compounds for inhibition of tumor necrosis factor alpha
    发明人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P
    权利人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P; ENSEMBLE THERAPEUTICS CORP
    摘要:Disclosed herein are macrocyclic compounds and methods for their synthesis and use. In particular, macrocyclic compounds are disclosed that modulate the activity of tumor necrosis factor alpha and/or are useful in the treatment of medical conditions, such as, rheumatoid arthritis, psoriasis, and asthma.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知